Document Detail


Anemia in patients with heart failure and preserved systolic function.
MedLine Citation:
PMID:  16442914     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Anemia has been shown to be a predictor of mortality in patients with heart failure and impaired left ventricular systolic function (ISF). Although heart failure in the setting of preserved systolic function (PSF) is an important clinical problem, the relationship between anemia and outcomes in patients with PSF has not been carefully evaluated. METHODS: Patients undergoing diagnostic angiography from 1995 to 2003 with symptomatic heart failure (New York Heart Association class II or greater) were studied (N = 4951). Patients with primary valvular or congenital heart disease were excluded. Patients with ejection fraction < or = 0.40 (N = 1858) were considered the ISF group, and patients with ejection fraction > 0.40 (N = 3093) were classified as the PSF group. Anemia was defined by the World Health Organization criteria (hemoglobin < 13 g/dL for men and < 12 g/dL for women). Multivariable Cox proportional hazards models were used to adjust for baseline differences. The possibility of a differential effect of anemia by systolic function was tested using an interaction term in the multivariable model. RESULTS: Anemia was independently associated with adverse outcomes across the study cohort (adjusted hazard ratio = 1.53, P < .0001). There was no interaction between anemia and systolic function (ISF vs PSF) in the multivariable model (P = .31 for interaction). The hazard ratio for anemia was 1.61 for PSF patients and 1.45 for ISF patients. CONCLUSIONS: Anemia is an independent predictor of mortality in heart failure, regardless of whether patients have preserved or impaired systolic function. This is the first report of an association between anemia and increased mortality in patients with heart failure and PSF. Future investigations of therapies for anemia in heart failure should consider including patients with PSF.
Authors:
G Michael Felker; Linda K Shaw; Wendy Gattis Stough; Christopher M O'Connor
Related Documents :
7669794 - Medical complications in male adolescents with anorexia nervosa.
19554414 - Supraclavicular failure after breast-conserving therapy in patients with four or more p...
6933324 - Attendance failure at paediatric medical outpatient clinics.
19006114 - Safety of spironolactone use in ambulatory heart failure patients.
11435294 - Clinical and virologic characteristics of chronic active epstein-barr virus infection.
19863314 - Bedside therapeutic experiences with horizontal canal benign paroxysmal positional vert...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American heart journal     Volume:  151     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-01-30     Completed Date:  2006-02-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  457-62     Citation Subset:  AIM; IM    
Affiliation:
Duke Clinical Research Institute, Durham, NC 27705, USA. michael.felker@duke.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anemia / complications,  mortality*,  physiopathology
Female
Heart Failure / complications,  mortality*,  physiopathology
Heart Rate / physiology
Hemoglobin A / analysis
Humans
Male
Middle Aged
Prognosis
Proportional Hazards Models
Retrospective Studies
Risk Assessment
Stroke Volume / physiology
Survival Analysis
Systole
Ventricular Dysfunction, Left / physiopathology
Ventricular Function, Left / physiology*
Grant Support
ID/Acronym/Agency:
K23 HL72357-01A1/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
9034-51-9/Hemoglobin A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A cooperative network of trained sites for the conduct of a complex clinical trial: a new concept in...
Next Document:  Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, cl...